immunity from liability; to regulate and prohibit the sale and offering for sale of drug paraphernalia under
certain circumstances; to provide for the implementation of federal law; to provide for penalties and
remedies; to provide for sanctions for violations of this act and local ordinances; to provide for an
appropriation and supplements; to repeal certain acts and parts of acts; to repeal certain parts of this act; and
to repeal certain parts of this act on specific dates,” by amending sections 17210 and 17708 (MCL 333.17210
and 333.17708), section 17210 as amended by 2017 PA 22 and section 17708 as amended by 2020 PA 4.
(The bill was enrolled earlier today, see today’s Journal, p. 1248.)
Rep. Frederick moved to reconsider the vote by which the House concurred in the Senate substitute (S-4).
The motion prevailed, a majority of the members serving voting therefor.
The question being on concurring in the substitute (S-4) made to the bill by the Senate,
The substitute (S-4) was concurred in, a majority of the members serving voting therefor, by yeas and nays,
as follows: